BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1698898)

  • 21. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of outcome in small cell carcinoma of the cervix--a case series.
    Straughn JM; Richter HE; Conner MG; Meleth S; Barnes MN
    Gynecol Oncol; 2001 Nov; 83(2):216-20. PubMed ID: 11606074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of histologic type on survival after curative resection for undifferentiated lung cancer.
    Mayer JE; Ewing SL; Ophoven JJ; Sumner HW; Humphrey EW
    J Thorac Cardiovasc Surg; 1982 Nov; 84(5):641-8. PubMed ID: 6290802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrin releasing peptide in human neuroendocrine tumours.
    Bostwick DG; Bensch KG
    J Pathol; 1985 Dec; 147(4):237-44. PubMed ID: 3003308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
    Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokeratin-negative desmoplastic small round cell tumor: a report of two cases emphasizing the utility of reverse transcriptase-polymerase chain reaction.
    Trupiano JK; Machen SK; Barr FG; Goldblum JR
    Mod Pathol; 1999 Sep; 12(9):849-53. PubMed ID: 10496592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
    Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
    Anticancer Res; 1989; 9(6):1717-20. PubMed ID: 2560624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of patients with small cell carcinoma of the lung: a histochemical and immunohistochemical study.
    Ishida T; Nishino T; Oka T; Yasumoto K; Sugimachi K; Hara N; Ohta M
    J Surg Oncol; 1989 Mar; 40(3):188-93. PubMed ID: 2465455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases.
    Lopez JI; Angulo JC; Flores N; Toledo JD
    Br J Urol; 1994 Jan; 73(1):43-9. PubMed ID: 7507782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large cell carcinoma of the lung. Prognostic implications of histopathologic and immunohistochemical subtyping.
    Ishida T; Kaneko S; Tateishi M; Oka T; Mitsudomi T; Sugimachi K; Hara N; Ohta M
    Am J Clin Pathol; 1990 Feb; 93(2):176-82. PubMed ID: 2154087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-cell-type poorly differentiated squamous cell carcinoma of the lung. Cytologic, immunohistochemical and nuclear DNA content analysis.
    Abe S; Ogura S; Nakajima I; Makimura S; Kawakami Y; Inoue K
    Anal Quant Cytol Histol; 1990 Apr; 12(2):73-7. PubMed ID: 1693507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of CD56, as a potential diagnostic marker, in small cell carcinoma].
    Yun JP; Xiang J; Hou JH; Tian QH; Fu J
    Ai Zheng; 2005 Sep; 24(9):1140-3. PubMed ID: 16159442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrapulmonary small cell carcinoma of the liver: clinicopathological and immunohistochemical findings.
    Choi SJ; Kim JM; Han JY; Ahn SI; Kim JS; Kim L; Park IS; Chu YC
    Yonsei Med J; 2007 Dec; 48(6):1066-71. PubMed ID: 18159605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple hormone production in an oat cell carcinoma of the larynx.
    Bishop JW; Osamura RY; Tsutsumi Y
    Acta Pathol Jpn; 1985 Jul; 35(4):915-23. PubMed ID: 2416185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cytologic markers for automated lung cancer screening.
    Uei Y; Noguchi Y
    Anal Quant Cytol Histol; 1990 Oct; 12(5):327-32. PubMed ID: 1702634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical significance of variant-morphology small-cell carcinoma of the lung.
    Aisner SC; Finkelstein DM; Ettinger DS; Abeloff MD; Ruckdeschel JC; Eggleston JC
    J Clin Oncol; 1990 Mar; 8(3):402-8. PubMed ID: 2155311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral small cell undifferentiated carcinoma of the lung. Clinicopathologic features of 17 cases.
    Gephardt GN; Grady KJ; Ahmad M; Tubbs RR; Mehta AC; Shepard KV
    Cancer; 1988 Mar; 61(5):1002-8. PubMed ID: 2827882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.